TONI BRONFENBRENER: Open Payments
NPI 1740793215 · SOUTHAMPTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,394 in 267 payments from 25 companies in 2025. Trend: 2023 $7,257 · 2024 $7,462 · 2025 $5,394
Food & beverage: $5,314Education: $80
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 61 | $943 |
| Janssen Biotech, Inc. | 43 | $836 |
| Galderma Laboratories, L.P. | 19 | $497 |
| Organon LLC | 19 | $433 |
| Novartis Pharmaceuticals Corporation | 18 | $320 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $252 |
| UCB, Inc. | 10 | $247 |
| Incyte Corporation | 13 | $239 |
| Arcutis Biotherapeutics, Inc. | 7 | $237 |
| GENZYME CORPORATION | 9 | $196 |
Products named: TREMFYA, SKYRIZI, NEMLUVIO, RINVOQ, DUPIXENT, COSENTYX, Bimzelx, OPZELURA.
Industry payments across PA — which companies pay providers there.
